Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

44 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Natural history of t(11;14) multiple myeloma.
Lakshman A, Alhaj Moustafa M, Rajkumar SV, Dispenzieri A, Gertz MA, Buadi FK, Lacy MQ, Dingli D, Fonder AL, Hayman SR, Hobbs MA, Gonsalves WI, Hwa YL, Kapoor P, Leung N, Go RS, Lin Y, Kourelis TV, Lust JA, Russell SJ, Zeldenrust SR, Kyle RA, Kumar SK. Lakshman A, et al. Among authors: alhaj moustafa m. Leukemia. 2018 Jan;32(1):131-138. doi: 10.1038/leu.2017.204. Epub 2017 Jun 27. Leukemia. 2018. PMID: 28655925
Timeliness of Initial Therapy in Multiple Myeloma: Trends and Factors Affecting Patient Care.
Kumar V, Alhaj-Moustafa M, Bojanini L, Sher T, Roy V, Manochakian R, Vishnu P, Bodepudi S, Shareef Z, Ahmed S, Jani P, Paulus A, Grover A, Alegria VR, Ailawadhi M, Chanan-Khan A, Ailawadhi S. Kumar V, et al. Among authors: alhaj moustafa m. JCO Oncol Pract. 2020 Apr;16(4):e341-e349. doi: 10.1200/JOP.19.00309. Epub 2020 Jan 21. JCO Oncol Pract. 2020. PMID: 32048939
Outcomes of Hepatosplenic T-Cell Lymphoma: The Mayo Clinic Experience.
Bojanini L, Jiang L, Tun AJ, Ayala E, Menke DM, Hoppe B, Kharfan-Dabaja MA, Tun HW, Alhaj Moustafa M. Bojanini L, et al. Among authors: alhaj moustafa m. Clin Lymphoma Myeloma Leuk. 2021 Feb;21(2):106-112.e1. doi: 10.1016/j.clml.2020.09.013. Epub 2020 Oct 5. Clin Lymphoma Myeloma Leuk. 2021. PMID: 33160933
Daratumumab-lenalidomide and daratumumab-pomalidomide in relapsed lenalidomide-exposed or refractory multiple myeloma.
Alhaj Moustafa M, Parrondo R, Abdulazeez MF, Roy V, Sher T, Alegria VR, Warsame RM, Fonseca R, Rasheed A, Gonsalves WI, Kourelis T, Kapoor P, Buadi FK, Dingli D, Hayman SR, Reeder CB, Chanan-Khan AA, Ailawadhi S. Alhaj Moustafa M, et al. Anticancer Drugs. 2024 Jan 1;35(1):63-69. doi: 10.1097/CAD.0000000000001520. Epub 2023 Apr 6. Anticancer Drugs. 2024. PMID: 37067996
Myelomatous ascites and pleural effusion in relapsed multiple myeloma.
Baksh M, Li K, Jiang L, Alegria V, Sher T, Roy V, Chanan-Khan A, Ailawadhi S, Parrondo RD, Alhaj Moustafa M. Baksh M, et al. Among authors: alhaj moustafa m. Clin Case Rep. 2022 Feb 2;10(2):e05329. doi: 10.1002/ccr3.5329. eCollection 2022 Feb. Clin Case Rep. 2022. PMID: 35140947 Free PMC article.
Clinical characteristics, prognostic indicators, and survival outcomes in intravascular lymphoma: Mayo Clinic experience (2003-2018).
Seegobin K, Li Z, Alhaj Moustafa M, Majeed U, Wang J, Jiang L, Kuhlman J, Menke D, Li K, Kharfan-Dabaja MA, Ayala E, Iqbal M, Nowakowski GS, Habermann TM, Witzig TE, Johnston P, Thompson C, Ansell S, Tun HW. Seegobin K, et al. Among authors: alhaj moustafa m. Am J Hematol. 2022 Sep;97(9):1150-1158. doi: 10.1002/ajh.26635. Epub 2022 Jul 6. Am J Hematol. 2022. PMID: 35713565 Free PMC article.
44 results